Connect with us

Politics

Oregon Officials Explain How Decriminalized Drugs And Legal Psilocybin Therapy Would Impact The State

Published

on

Oregon officials finalized a series of analyses this week on separate ballot measures to legalize psilocybin mushrooms for therapeutic use and decriminalize drugs while investing in substance misuse treatment.

The Oregon Criminal Justice Commission determined that the decriminalization initiative would reduce felony and misdemeanor convictions for drug possession by 91 percent, and that reduction would be “substantial for all racial groups, ranging from 82.9% for Asian Oregonians to approximately 94% for Native American and Black Oregonians.”

Overall, the policy change would result in a 95 percent drop in racial disparities for possession arrests, the panel projects.

“The CJC estimates that IP 44 will likely lead to significant reductions in racial/ethnic disparities in both convictions and arrests.”

The conviction estimate was included in the panel’s draft analysis first released last month, but the final version was expanded to include the arrest data as well. The new document also notes that “disparities can exist at different stages of the criminal justice process, including inequities in police stops, jail bookings, bail, pretrial detention, prosecutorial decisions, and others”—a point that activists hoped the panel would include.

That said, the commission noted it “lacks sufficient or appropriate data in each of these areas and therefore cannot provide estimates for these other stages.”

The new report, published on Wednesday, cites research indicating that the resulting “drop in convictions will result in fewer collateral consequences stemming from criminal justice system involvement, which include difficulties in finding employment, loss of access to student loans for education, difficulties in obtaining housing, restrictions on professional licensing, and others.”

The decriminalization proposal was the first ballot initiative in the state’s history to receive a report on the racial justice implications of its provisions under a little-utilized procedure where lawmakers can request such an analysis.

This information will be included in a voter pamphlet as a factual statement from the secretary of state’s office.

“Our current drug laws can ruin lives based on a single mistake, sticking you with a lifelong criminal record that prevents you from getting jobs, housing and more,” Bobby Byrd, an organizer with the More Treatment, A Better Oregon campaign, said in a press release.

Both the psilocybin therapy and drug decriminalization measures also received final explanatory statements and fiscal impact statements this week.

For the therapeutic psilocybin legalization initiative, the Financial Estimate Committee said that it projects the measure will have an impact of $5.4 million from the general fund during the two-year development period. After the program is established, it will cost $3.1 million annually, “which will be covered by the fees and tax funds for the administration and enforcement of the Act.”

The explanatory statement says the measure “directs the Oregon Health Authority to regulate the manufacture, delivery, purchase, and consumption of psilocybin, a psychoactive component found in certain mushrooms, at licensed psilocybin service centers” and that a “person would be allowed to purchase, possess, consume, and experience the effects of psilocybin only at a licensed psilocybin service center during a psilocybin administration session with a licensed psilocybin service facilitator.”

It also describes an initial two-year development period during which officials will research and make recommendations on “the safety and efficacy of using psilocybin to treat mental health conditions,” after which time the new law will allow “a client who is at least 21 years of age to purchase, possess, consume, and experience the effects of psilocybin at a licensed psilocybin service center during a psilocybin administration session with a licensed psilocybin service facilitator.”

Sam Chapman, campaign manager for the psilocybin initiative, told Marijuana Moment that the group is “satisfied with the explanatory statement and believe it captures the thoughtful approach we took that led to psilocybin therapy being on the ballot this November.”

“Specifically, we were happy to see the regulations and safeguards that are built into the measure highlighted in the explanatory statement,” he said. “We also believe that the fiscal committee saw and respected our approach to keep the psilocybin therapy program revenue neutral once up and running.”

The drug possession decriminalization measure is expected to cost $57 million annually, according to state officials, but it will be covered by marijuana tax revenue, which is “estimated at $61.1 million in 2019-21 and $182.4 million in 2021-23” and would therefore be “sufficient to meet this requirement.” Cannabis revenue to cities and counties would be reduced under the measure.

The reform would also save money through reduced drug enforcement. “These savings are estimated at $0.3 million in 2019-21 and $24.5 million in 2021-23,” the analysis says. “This will reduce revenue transferred from the Department of Corrections for local government community corrections by $0.3 million in 2019-21 and $24.5 million in 2021-23. The savings are expected to increase beyond the 2021-23 biennium.”

The initiative “mandates the establishment of at least one addiction recovery center in each existing coordinated care organization service area in the state,” the separate explanatory statement says, and describes how they would be funded with marijuana tax revenue.

“The measure eliminates criminal penalties for possession of specified quantities of controlled substances by adults and juveniles,” it says. “Instead, possession of these specified quantities of controlled substances becomes a non-criminal Class E violation for which the maximum punishment is a $100 fine or completion of a health assessment with an addiction treatment professional.”

Here’s a status update on other 2020 drug policy reform campaigns across the country: 

A measure to effectively decriminalize a wide range of psychedelics has officially qualified for the November ballot in Washington, D.C.

Montana activists said last month that county officials have already certified that they collected enough signatures to place two marijuana legalization measure on the state ballot, though the secretary of state’s office has yet to make that official.

In Arizona, the organizers of a legalization effort turned in 420,000 signatures to qualify for the ballot last month.

Organizers in Nebraska last month submitted 182,000 signatures in an attempt to put a medical marijuana measure on November’s ballot.

Idaho activists behind a medical marijuana legalization initiative were hoping to get a second wind after a federal judge said recently that the state must make accommodations for a separate ballot campaign due to signature gathering complications caused by the coronavirus pandemic. But following a recent U.S. Supreme Court ruling against the other group, hopes are dashed.

Prior to the COVID-19 outbreak and stay-at-home mandates, separate measures to legalize marijuana for medical and recreational purposes qualified for South Dakota’s November ballot.

The New Jersey legislature approved putting a cannabis legalization referendum before voters as well.

And in Mississippi, activists gathered enough signatures to qualify a medical cannabis legalization initiative for the ballot—though lawmakers also approved a competing (and from advocates’ standpoint, less desirable) medical marijuana proposal that will appear alongside the campaign-backed initiative.

A campaign to legalize cannabis in Missouri officially gave up its effort for 2020 due to signature collection being virtually impossible in the face of social distancing measures.

North Dakota marijuana legalization activists are shifting focus and will seek qualification for the 2022 ballot.

Washington State activists had planned to pursue a drug decriminalization and treatment measure through the ballot, but citing concerns about the COVID-19 outbreak, they announced last month that they will be targeting the legislature instead.

Read the full state analysis of the Oregon drug decriminalization and psilocybin therapy measures below:

Oregon Drug Decrim And Psil… by Marijuana Moment on Scribd

Texas Lawsuit Challenges State’s New Ban On Smokable Hemp

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Kyle Jaeger is Marijuana Moment's Los Angeles-based associate editor. His work has also appeared in High Times, VICE and attn.

Politics

Vermont Bill To Legalize Marijuana Sales One Step Away From Governor’s Desk After House Vote

Published

on

The Vermont House of Representatives on Thursday approved a finalized version of a bill to legalize, tax and regulate marijuana sales in the state.

While both the House and Senate had previously passed the bill, S. 54, a bicameral conference committee had to be convened to resolve differences between their respective versions. And following a series of meetings and compromises, negotiators on the panel reached a deal on Tuesday, sending the final proposal back to the floor of both chambers for final consent.

The House approved the compromise legislation in a 92-56 vote. It’s expected to be taken up by the Senate next week, and if it passes there as well, it will head to the the desk of Gov. Phil Scott (R).

Vermont legalized possession of up to one ounce of cannabis and cultivation of two plants in 2018, but there are currently no regulations in place that allow for retail sales.

“It’s exciting to see that Vermont is on the cusp of ending cannabis prohibition for adults,” Matt Simon, New England political director of the Marijuana Policy Project, said in a press release. “Most Vermonters are not interested in growing their own plants, and many are unable to do so because it is prohibited by their rental agreements, so the only sensible policy is to create a regulated market for adult-use cannabis in Vermont. Governor Scott should recognize the merits of this bill and sign it into law after it passes the Senate.”

Under the proposed bill, cannabis would be subject to a 14 percent excise tax, in addition to the state’s six percent sales tax.

S. 54 also contains some social equity provisions such as prioritizing marijuana business licenses for minorities, women and people disproportionately impacted by the war on drugs. An independent regulatory commission would additionally be tasked with promoting small business participation in the market.

A new Cannabis Control Commission would be responsible for issuing licenses for retailers, growers, manufacturers, wholesalers and labs. The body would also take over regulation of the state’s existing medical cannabis industry from the Department of Public Safety .

A 30 percent THC limit would be imposed on cannabis flower, while oils could contain up to 60 percent THC. Flavored vape cartridges would be banned.

“Why do we tax and regulate and control particular substances? We have several reasons,” Rep. Tommy Walz (D) said during the House’s debate prior to voting on the legislation. “One, of course, is that we can get revenue out of it. But also because we can provide some harm reduction. It can provide some protections.”

Local jurisdictions would have to proactively opt in to allow marijuana businesses to operate in their area. Municipalities would also be able to establish their own regulations and municipal licensing requirements.

The three House and three Senate members charged with negotiating the final bill had at times contentious meetings where they hashed out issues such as tax rates, local control, advertising, saliva testing of drivers and even an unrelated seat belt enforcement provision the House unsuccessfully pushed to insert.

Rep. Anne Donahue (R) gave an extensive speech where she agreed fundamentally with the purpose of the legislation.

“Why do we want a tax and regulate sales system for marijuana in Vermont? I think we have a list of pretty good reasons,” she said. “We began with the acknowledgement that this is something that people are using and, in fact, are using legally in Vermont. We want to divert it from the black market. The only way to do that is to create a tax and regulate legal market.”

But ultimately she said the lack of a total ban on advertising and marketing left her opposed to the measure. The contention over advertising occupied much of Thursday’s discussion.

timeline for the legislation states that it would formally take effect on October 1, 2020—but regulators would then have to make a series of determinations about rules and licensing before retail sales would launch. Dispensary licenses would have to be issued on or before October 1, 2022.

A fiscal analysis on the final bill projects that Vermont will generate between $13.3 million and $24.2 million in annual cannabis tax revenue by Fiscal Year 2025. Licensing fees will lead to additional funds for the state, but the regulatory board created by the legislation will set those levels at a later date. For now, the Joint Fiscal Office estimates the fees could lead to another $650,000 in revenue every year. Municipalities hosting marijuana businesses will also be able to levy additional local fees.

The governor hasn’t indicated whether he’s supportive of the newly revised legislation, but a top legislator said earlier this year that he’s been “at the table” in earlier negotiations and has expressed interest in using some tax revenue to fund an after-school program he’s pursuing. That said, Scott only reluctantly signed the legalization of possession and homegrow into law after vetoing an earlier version, and it’s not clear if the road safety provisions in the final commercialization bill will be enough to satisfy concerns he has voiced about impaired driving.

Outside of the cannabis sales legalization bill, the House approved separate legislation this month that would provide for automatic expungements of marijuana convictions and allow people to possess and grow more cannabis without the threat of jail time than is currently allowed. The Senate could give approval to the latest version next week, setting it up to head to Scott’s desk.

This story has been updated to include comments from lawmakers during the vote.

Slim Majority Of Arizona Voters Support Marijuana Legalization Ballot Measure, New Poll Finds

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

House Postpones Vote On Bill To Federally Legalize Marijuana Until After Election

Published

on

A bill to federally legalize marijuana will no longer receive a previously announced vote in the House of Representatives next week.

In an at least temporary blow to reform advocates, the legislation was not included in a weekly floor schedule posted by the office of Majority Leader Steny Hoyer (D-MD) on Thursday, though he made a commitment that the body would bring up the bill sometime “later this autumn,” presumably after the November elections. This comes two weeks after Hoyer initially said a vote was being planned for the week of September 21.

“The MORE Act remains a critical component of House Democrats’ plan for addressing systemic racism and advancing criminal justice reform, and we are committed to bringing it to the Floor for a vote before the end of the year,” Hoyer said. “Right now, the House is focused relentlessly on securing agreement to stave off a damaging government shutdown and continuing to do its job addressing the COVID-19 pandemic. Later this autumn, the House will pass the MORE Act with strong support as yet another crucial step toward making our justice system fair for all Americans.”

It appears that the decision was influenced by certain moderate Democrats who’ve expressed concern that voting on a cannabis reform bill while another round of coronavirus relief legislation is still unresolved would be bad optics for their reelection campaigns.

There were some signals earlier this week that leadership was on the fence about advancing the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, with Hoyer saying on Tuesday that the priorities were passing a continuing resolution and COVID-19 relief bill.

That said, a representative from his office told Marijuana Moment at the time that the schedule hadn’t yet changed.

But now it’s been confirmed: the MORE Act will not get a vote next week.

Rep. Barbara Lee (D-CA), cochair of the Congressional Cannabis Caucus, said on Wednesday that she was open to delaying the vote if it meant that more members would sign onto it, but she also told Marijuana Moment that lawmakers would be “doing everything we can over the next week to build broad coalitions of support to ensure that happens sooner rather than later.”

In a joint statement on Thursday, Lee and Rep. Earl Blumenauer, another leading marijuana reform advocate in Congress, said they “have worked to build support for this historic legislation and expected a vote next week.”

“As Americans confront hundreds of years of systemic racial injustice, ending the failed war on drugs that has disproportionately hurt Black and Brown Americans must be front and center. As co-chairs of the Congressional Cannabis Caucus, our goal has always been a vote on federal marijuana legalization and restorative justice this Congress,” they said. “Thankfully, the leadership has now given an ironclad commitment that the House will consider the bill this fall. The public deserves this vote and we will continue to build support to meet our objective of passing the MORE Act in the House and sending it to the Senate, which is one step closer to enacting it into law.”

The MORE Act would federally deschedule cannabis, expunge the records of those with prior marijuana convictions and impose a federal five percent tax on sales, revenue from which would be reinvested in communities most impacted by the drug war.

It would also create a pathway for resentencing for those incarcerated for marijuana offenses, as well as protect immigrants from being denied citizenship over cannabis and prevent federal agencies from denying public benefits or security clearances due to its use.

Two-thirds of Americans favor legalizing marijuana, according to a Gallup poll released late last year. That includes a majority of Republicans (51 percent) and a supermajority of Democrats (76 percent).

Despite the delay, which was first reported by Politico and The Hill, if and when the bill does eventually come up for a vote, it stands to have at least some bipartisan support.

Rep. Don Young (R-AK) recently said he was “confident” it would pass the chamber.

Rep. Matt Gaetz (R-FL), the sole GOP cosponsor on the bill, said earlier this month that he would be voting “yes” on the MORE Act, though he expressed criticism about a provision that would impose a federal excise tax on marijuana sales to be reinvested in communities most impacted by the drug war, calling them “reparations.”

Rep. Tom McClintock (R-CA) also said “I intend to vote yes on the bill” in a recent interview with Politico. “With respect to timing, I do find it ironic that the only small businesses the Democrats seem to be worried about is cannabis shops, but I would support this bill whenever it is brought to a vote,” he said.

McClintock, along with Gaetz, voted for the MORE Act when it was marked up by the Judiciary Committee last year.

The bill stood a chance to bringing on other GOP supporters as well.

A spokesperson for Rep. Rodney Davis (R-IL) told Marijuana Moment that he “supports decriminalizing marijuana at the federal level and removing cannabis from the Controlled Substances Act” and “believes that states individually should be able to determine their own marijuana policies, not the federal government” but would “wait and see what final bill the House Democrats put on the floor and if they will attempt to amend it” before deciding whether he would vote yes.

A total of 31 Republicans House members voted in favor of a floor amendment in July that would prevent the Department of Justice from interfering with state marijuana laws.

Legalization advocates are disappointed that House leaders reneged on their previously announced plan to vote on the broader legalization bill this month.

“Though it appears to be a temporary delay, we are seriously disappointed by this news as time and time again, communities directly impacted by systemic injustices are made to wait for justice and change,” Queen Adesuyi, policy manager with the Drug Policy Alliance, told Marijuana Moment. “While Congress waits on a more ‘politically convenient’ time to pass a wildly popular, bipartisan issue, individuals and families will continue to be robbed of employment opportunities, housing, education, public benefits—even their children—due to a plant that is at the center of what is estimated to be a billion dollar industry.”

“It’s reprehensible to say the least,” she said. “We hope to see Members of Congress’ commitment to racial justice actualized through the swift passage of the MORE Act in November.”

Advocates said they maintained hope that reform will continue to have momentum at all levels of government.

“This delay by the House does not change the fact that the overwhelming majority of voters support ending the federal prohibition of cannabis, including majorities of Democrats, independents, and Republicans,” NORML Political Director Justin Strekal said. “This delay does not change the fact that 33 states and the District of Columbia regulate the production and distribution of medical cannabis in a manner that is inconsistent with federal policy, and that one-out-of-four Americans now reside in jurisdictions where adult-use is legal under state law.”

“This delay does not change the fact that voters in several states, including key electoral battleground states for both control of the presidency and the Senate, will be passing similar state-level marijuana measures on Election Day,” he added.

Meanwhile, opponents of legalization, including Rep. Andy Harris (R-MD) and the prohibitionist group Smart Approaches To Marijuana, are celebrating the development.

This vote delay is the latest disappointment that reform advocates have experienced from the Democratic party of late. They were hopeful, for example, that the party would nominate a presidential candidate who would support legalization after most primary contenders went on record in favor of the change—but nominee Joe Biden remains opposed and backs more modest proposals such as possession decriminalization and expungements.

The Democratic National Committee’s platform committee in July voted against an amendment that would’ve added legalization as a 2020 party plank—a move that some suspect was influenced by a desire not to formally endorse a policy opposed by Biden.

In light of that, some advocates are concerned that if the Democratic House doesn’t go on record by passing bold marijuana reform this year, it may be reluctant to send a would-be President Biden a legalization bill that he does not want in 2021.

This story was updated to include comments from Hoyer, Lee, Blumenauer, NORML and Drug Policy Alliance.

Marijuana Consumer Group Launches Nationwide Get-Out-The-Vote Campaign

Image element courtesy of Tim Evanson.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Slim Majority Of Arizona Voters Support Marijuana Legalization Ballot Measure, New Poll Finds

Published

on

The campaign behind an initiative to legalize marijuana in Arizona has their work cut out for them in the coming weeks, as a new poll shows that just a slim majority of voters support the ballot measure.

According to the poll, which was conducted by Monmouth University, 51 percent of respondents said they back the proposal, while 41 percent are against it. Six percent are undecided, while another three percent of voters said they would skip the cannabis measure on the ballot.

Via Monmouth University.

The firm ran multiple scenarios, and found that support dips to 49 percent and opposition rises to 43 percent in a high turnout model, while a low turnout situation puts the measure at 47 percent for and 47 percent against.

With weeks before the election, activists will have to do what they can to make their margin of support more comfortable. That said, a separate survey that a different polling company released in July found that significantly more Arizonans support the policy change, with 62 percent saying the state should legalize cannabis.

For this latest poll, Democrats were the most likely to back the initiative at 67 percent. Fifty-nine percent of independents and 32 percent of Republicans said they would vote for the measure.

Sixty percent of voters aged 18 to 49 said they will vote for the legalization measure, and a majority of to-64 year-olds did as well. Voters over 65 oppose it by a margin of 34 percent to 59 percent.

Interestingly, households with military service members or veterans were especially supportive of the proposal, with 57 percent of respondents in that group saying they favor legalization, with only 47 percent of non-military or vet households being on board.

The poll also showed Democratic vice presidential nominee Joe Biden leading President Donald Trump in the state, 48 percent to 44 percent.

Last month, Trump voiced concern that putting marijuana measures on state ballots boosts Democratic turnout and makes Republicans lose elections.

The survey involved interviews with 420 Arizona registered voters from September 11-15 and has a margin of error of +/- 4.8 percentage points.

Activists turned in about 420,000 raw signatures for the cannabis legalization initiative in July, and it officially qualified last month.

Under the measure, adults could possess up to an ounce of marijuana at a time and cultivate up to six plants for personal use.

The initiative also contains several restorative justice provisions such as allowing individuals with prior marijuana convictions to petition the courts for expungements and establishing a social equity ownership program

Cannabis sales would be taxed at 16 percent. Tax revenue would cover implementation costs and then would be divided among funds for community colleges, infrastructure, a justice reinvestment and public services such as police and firefighters.

The Department of Health Services would be responsible for regulating the program and issuing cannabis business licenses. It would also be tasked with deciding on whether to expand the program to allow for delivery services.

Arizona voters narrowly rejected an earlier marijuana legalization initiative in 2016.

Marijuana Consumer Group Launches Nationwide Get-Out-The-Vote Campaign

Photo courtesy of Chris Wallis // Side Pocket Images.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Do NOT follow this link or you will be banned from the site!